Articles dans des revues avec comité de lecture (7)
  1. 1. Gilglioni, E. H., Bansal, M., St-Pierre-Wijckmans, W., Talamantes, S., Kasarinaite, A., Hay, D. C., & Gurzov, E. N. (2025). Therapeutic potential of stem cell-derived somatic cells to treat metabolic dysfunction-associated steatotic liver disease and diabetes. Obesity reviews, e13899. doi:10.1111/obr.13899
  2. 2. Pérez-Chávez, I., Koberstein, J. J., Pueyo, J. M., Gilglioni, E. H., Vertommen, D., Baeyens, N., Ezeriņa, D., Gurzov, E. N., & Messens, J. (2024). Tracking fructose 1,6-bisphosphate dynamics in liver cancer cells using a fluorescent biosensor. iScience, 27(12), 111336. doi:10.1016/j.isci.2024.111336
  3. 3. Gilglioni, E. H., Li, A., St-Pierre-Wijckmans, W., Shen, T.-K., Perez Chavez, I., Hovhannisyan, G., Lisjak, M., Negueruela Escudero, J., Vandenbempt, V., Bauzá-Martinez, J., Herranz, J. M., Ezeriņa, D., Demine, S., Feng, Z., Vignane, T., Otero Sanchez, L., Lambertucci, F., Prašnická, A., Devière, J., Hay, D. C., Encinar, J. A., Singh, S. P., Messens, J., Filipovic, M. R., Sharpe, H. J., Trepo, E., Wu, W., & Gurzov, E. N. (2024). PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity. Nature communications, 15(1), 9522. doi:10.1038/s41467-024-53733-0
  4. 4. Bizerra, P. F. V., Gilglioni, E. H., Li, H. L., Go, S., Oude Elferink, R. R., Verhoeven, A. A., & Chang, J. C. (2024). Opposite regulation of glycogen metabolism by cAMP produced in the cytosol and at the plasma membrane. Biochimica et biophysica acta. Molecular cell research, 1871(1), 119585. doi:10.1016/j.bbamcr.2023.119585
  5. 5. Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C., Ramos-Molina, B., & Gurzov, E. N. (2023). Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports, 100811. doi:10.1016/j.jhepr.2023.100811
  6. 6. Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.101681
  7. 7. Brahma, M. K., Gilglioni, E. H., Zhou, L., Trepo, E., Chen, P., & Gurzov, E. N. (2021). Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges. Oncogene. doi:10.1038/s41388-021-01950-y